Spiriva HandiHaler 18 ug/1

Spiriva HandiHaler 18 ug/1 capsules are a respiratory medication designed for inhalation. They contain tiotropium bromide, a bronchodilator used to manage chronic obstructive pulmonary disease (COPD) symptoms. This medication helps improve breathing by relaxing the muscles in the airways.

Spiriva HandiHaler 18 ug/1 capsules are primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This includes conditions like chronic bronchitis and emphysema. The medication works by opening the airways, making it easier to breathe. It is not intended for the relief of acute bronchospasm or the treatment of asthma.

Common effects of Spiriva HandiHaler 18 ug/1 capsules may include dry mouth, throat irritation, and cough. Some users might experience headaches or dizziness. These effects are generally mild and temporary. If any effects persist or worsen, it is advisable to consult a healthcare professional.

Spiriva HandiHaler 18 ug/1 capsules should be used with caution in individuals with a history of urinary retention or narrow-angle glaucoma. It is important to follow the prescribed dosage and administration instructions carefully. The capsules should be stored in a cool, dry place away from direct sunlight.

Spiriva HandiHaler 18 ug/1 capsules may interact with other medications, including anticholinergics and antihistamines. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.